688117 圣诺生物
已收盘 12-20 15:00:00
资讯
新帖
简况
圣诺生物:未来如有相关事项且达到披露标准,公司将根据上海证券交易所相关规定及时履行信息披露义务
证券之星 · 12-13
圣诺生物:未来如有相关事项且达到披露标准,公司将根据上海证券交易所相关规定及时履行信息披露义务
圣诺生物12月09日获主力加仓229万元 环比增加3171.43%
市场透视 · 12-09
圣诺生物12月09日获主力加仓229万元 环比增加3171.43%
圣诺生物涨5% 生物医药产业受关注
智选洞察 · 12-02
圣诺生物涨5% 生物医药产业受关注
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
圣诺生物跌5% 近半年3券商增持
智选洞察 · 11-22
圣诺生物跌5% 近半年3券商增持
概念掘金 | 司美格鲁肽减肥药正式在中国上市,多家电商平台已上线
格隆汇 · 11-17
概念掘金 | 司美格鲁肽减肥药正式在中国上市,多家电商平台已上线
圣诺生物大跌5.12% 3家券商给予增持建议
智选洞察 · 11-13
圣诺生物大跌5.12% 3家券商给予增持建议
圣诺生物(688117)11月11日主力资金净卖出514.20万元
证券之星 · 11-12
圣诺生物(688117)11月11日主力资金净卖出514.20万元
11月11日圣诺生物涨7.75%,圆信永丰聚优股票A基金重仓该股
证券之星 · 11-11
11月11日圣诺生物涨7.75%,圆信永丰聚优股票A基金重仓该股
圣诺生物涨7.75%,开源证券一周前给出“买入”评级
证券之星 · 11-11
圣诺生物涨7.75%,开源证券一周前给出“买入”评级
圣诺生物大幅上涨 获3家券商给予增持建议
智选洞察 · 11-11
圣诺生物大幅上涨 获3家券商给予增持建议
10月31日圣诺生物发布公告,其股东减持56.14万股
证券之星 · 10-31
10月31日圣诺生物发布公告,其股东减持56.14万股
开源证券:给予圣诺生物买入评级
证券之星 · 10-31
开源证券:给予圣诺生物买入评级
圣诺生物:Q3业绩快速增长 大订单落地助推中长期发展
开源证券 · 10-31
圣诺生物:Q3业绩快速增长 大订单落地助推中长期发展
圣诺生物大幅上涨 获融资净买入818万元
智选洞察 · 10-29
圣诺生物大幅上涨 获融资净买入818万元
图解圣诺生物三季报:第三季度单季净利润同比增140.02%
证券之星 · 10-29
图解圣诺生物三季报:第三季度单季净利润同比增140.02%
圣诺生物(688117.SH)发布前三季度业绩 净利润5694.66万元 同比增长63.66%
智通财经 · 10-28
圣诺生物(688117.SH)发布前三季度业绩 净利润5694.66万元 同比增长63.66%
圣诺生物涨5.00% 深圳将支持创新药和创新医疗器械产业发展
智选洞察 · 10-28
圣诺生物涨5.00% 深圳将支持创新药和创新医疗器械产业发展
圣诺生物(688117)10月24日主力资金净卖出923.15万元
证券之星 · 10-25
圣诺生物(688117)10月24日主力资金净卖出923.15万元
圣诺生物大跌5.05% 4家券商给予增持建议
智选洞察 · 10-21
圣诺生物大跌5.05% 4家券商给予增持建议
加载更多
公司概况
公司名称:
成都圣诺生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-06-03
主营业务:
成都圣诺生物科技股份有限公司主营业务是多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。公司主要产品为制剂、原料药、药学研究服务、受托加工服务、定制生产。公司及子公司拥有发明专利32项、实用新型专利30项(其中2项同时取得国际专利)和大量非专利技术,先后获评国家级、省级科研和技术改造项目十余项。
发行价格:
17.90
{"stockData":{"symbol":"688117","market":"SH","secType":"STK","nameCN":"圣诺生物","latestPrice":27.7,"timestamp":1734678000000,"preClose":27.69,"halted":0,"volume":1323863,"delay":0,"floatShares":112000000,"shares":112000000,"eps":0.8228,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"12-20 15:00:00","open":27.75,"high":28.05,"low":27.6,"amount":36799100,"amplitude":0.0163,"askPrice":27.7,"askSize":60,"bidPrice":27.69,"bidSize":411,"shortable":0,"etf":0,"ttmEps":0.8228,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":27.69,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":30.46,"lowLimit":24.92,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112418556,"pbRate":3.39,"roa":"--","roe":"6.31%","epsLYR":0.63,"committee":0.67205,"marketValue":3114000000,"floatMarketCap":3114000000,"peRate":33.665533,"changeRate":0.0004,"turnoverRate":0.0118,"status":0,"afterMarket":{"amount":0,"volume":0,"close":27.7,"buyVolume":5000,"sellVolume":0,"time":1734680038975,"indexStatus":"已收盘 12-20 15:30:00","preClose":27.69}},"requestUrl":"/m/hq/s/688117","defaultTab":"news","newsList":[{"id":"2491329136","title":"圣诺生物:未来如有相关事项且达到披露标准,公司将根据上海证券交易所相关规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2491329136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491329136?lang=zh_cn&edition=full","pubTime":"2024-12-13 20:00","pubTimestamp":1734091212,"startTime":"0","endTime":"0","summary":"证券之星消息,圣诺生物12月13日在投资者关系平台上答复投资者关心的问题。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300041297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2490170767","title":"圣诺生物12月09日获主力加仓229万元 环比增加3171.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490170767","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490170767?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:21","pubTimestamp":1733728877,"startTime":"0","endTime":"0","summary":"12月09日, 圣诺生物股价涨0.44%,报收29.52元,成交金额5937万元,换手率1.78%,振幅2.86%,量比1.07。圣诺生物今日主力资金净流入229万元,上一交易日主力净流入7万元,今日环比增加3171.43%。|12月09日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|申昊科技|6.49%|#|一彬科技|5.87%|#|智能自控|5.30%|#|星德胜|5.21%|#|新瀚新材|5.15%|#|三丰智能|5.04%|#|铭科精技|4.63%|#|惠发食品|4.32%|#|蓝黛科技|4.11%|#|喜悦智行|3.87%|圣诺生物所在的化学制药行业,今日主力净流出1.61亿元,行业排名27/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209154332a1dfc8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209154332a1dfc8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2488447846","title":"圣诺生物涨5% 生物医药产业受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2488447846","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488447846?lang=zh_cn&edition=full","pubTime":"2024-12-02 13:08","pubTimestamp":1733116097,"startTime":"0","endTime":"0","summary":"资金动向截止发稿,圣诺生物获得主力净流出157万元,其中超大单流出17万元,大单流出139万元。主营业务及业绩圣诺生物公司主营业务为多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202130830a265506b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202130830a265506b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161726","688117","399441","BK0239"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688139","688356","688575","688266","688670","600535","688617","603301","BK0185","600252","688105","600771","605199","600422","688247","603259","688506","600511","603658","688176","600721","600161","688276","600572","600200","603439","603707","688029","603309","688137","688046","600436","688488","603127","688091","688298","600055","688198","603882","688050","603538","688271","603896","600998","688212","600488","600739","600529","BK0028","688520","BK0188","688177","600211","688336","600085","688581","600129","688062","BK0070","600062","688626","688443","BK0012","605177","600867","688235","600079","603939","688180","688192","688166","688301","600080","688278","600763","688193","688656","688161","603233","600566","603567","600521","603392","688321","688687","688117","603456","688202","688315","600196","603590","688382","688067","159938","688085","688373","603108","688767","600285","600380","601607","688114","688351","688578","688389","BK0096","688566","688189","600976","688428","600056","688690","BK0239","600276","688222","603367","688076","600329","600420","600332","600851","688331","603087","688073","600351","688658","603858","688163","688221"],"gpt_icon":0},{"id":"2485284737","title":"圣诺生物跌5% 近半年3券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2485284737","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485284737?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:52","pubTimestamp":1732258378,"startTime":"0","endTime":"0","summary":"11月22日,圣诺生物股价大幅下跌,截至14点52分,圣诺生物下跌5.37%,报28.00元/股,成交9123万元,换手率2.83%,振幅5.34%。此外,数据统计显示,近半年内3家券商给予增持建议,10家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流入394万元,其中超大单流入758万元,大单流出363万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145958a24d3633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145958a24d3633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2484509265","title":"概念掘金 | 司美格鲁肽减肥药正式在中国上市,多家电商平台已上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2484509265","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484509265?lang=zh_cn&edition=full","pubTime":"2024-11-17 14:35","pubTimestamp":1731825344,"startTime":"0","endTime":"0","summary":"市场前景广阔","market":"hk","thumbnail":"https://img3.gelonghui.com/06664-7e9dde8e-9f54-49fb-a50c-81a04f916999.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/06664-7e9dde8e-9f54-49fb-a50c-81a04f916999.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1336126","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0154236417.USD","BK0132","603456","BK0196","LU1093756168.USD","688076","BK0114","BK4585","BK0201","BK0183","LU1064130708.USD","BK0028","LU1328615791.USD","01801","BK4007","LU1093756325.SGD","BK0239","300003","600276","BK0077","LU2488822045.USD","BK0060","BK0012","BK4532","BK0070","LU0405327148.USD","688117","IE00BKVL7J92.USD","BK0042","LU0405327494.USD","LU1064131003.USD","NVO","BK0113","002821","BK0188","IE00BZ1G4Q59.USD","300199","BK0251","LU2148510915.USD","BK4588"],"gpt_icon":1},{"id":"2483324016","title":"圣诺生物大跌5.12% 3家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483324016","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483324016?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:40","pubTimestamp":1731465615,"startTime":"0","endTime":"0","summary":"11月13日,圣诺生物股价大幅下跌,截至10点40分,圣诺生物下跌5.12%,报30.42元/股,成交7195万元,换手率2.05%。此外,数据统计显示,近半年内3家券商给予增持建议,10家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流出1626万元,其中超大单流出1580万元,大单流出44万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113104049a23223fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113104049a23223fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2482795729","title":"圣诺生物(688117)11月11日主力资金净卖出514.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482795729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482795729?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:16","pubTimestamp":1731370614,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月11日收盘,圣诺生物报收于31.69元,上涨7.75%,换手率6.27%,成交量7.03万手,成交额2.17亿元。近5日资金流向一览见下表:圣诺生物融资融券信息显示,融资方面,当日融资买入2776.37万元,融资偿还2119.77万元,融资净买入656.6万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200006540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2482488279","title":"11月11日圣诺生物涨7.75%,圆信永丰聚优股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482488279","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482488279?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:10","pubTimestamp":1731312602,"startTime":"0","endTime":"0","summary":"证券之星消息,11月11日圣诺生物涨7.75%,收盘报31.69元,换手率6.27%,成交量7.03万手,成交额2.17亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为圆信永丰聚优股票A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100019622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2482279111","title":"圣诺生物涨7.75%,开源证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482279111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482279111?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:09","pubTimestamp":1731312591,"startTime":"0","endTime":"0","summary":"今日圣诺生物涨7.75%,收盘报31.69元。2024年10月31日,开源证券研究员余汝意,汪晋发布了对圣诺生物的研报《公司信息更新报告:Q3业绩快速增长,大订单落地助推中长期发展》,该研报对圣诺生物给出“买入”评级。研报中预计2024-2026年归母净利润为1.06/1.39/1.86亿元,EPS为0.95/1.24/1.66元,当前股价对应PE为32.6/24.9/18.5倍,维持“买入”评级。圣诺生物个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100019617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","161027"],"gpt_icon":0},{"id":"2482245059","title":"圣诺生物大幅上涨 获3家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2482245059","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482245059?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:12","pubTimestamp":1731291166,"startTime":"0","endTime":"0","summary":"11月11日,圣诺生物股价大幅上涨,截至10点12分,圣诺生物上涨5.00%,报30.88元/股,突破30元整数关口,成交6266万元,换手率1.86%,振幅6.36%。此外,数据统计显示,近半年内3家券商给予增持建议,10家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流出203万元,其中超大单流入157万元,大单流出359万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111103505abb46723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111103505abb46723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2479080087","title":"10月31日圣诺生物发布公告,其股东减持56.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080087?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:01","pubTimestamp":1730368871,"startTime":"0","endTime":"0","summary":"证券之星消息,10月31日圣诺生物发布公告《圣诺生物:简式权益变动报告书(乐普医疗)》,其股东乐普(北京)医疗器械股份有限公司于2024年10月8日至2024年10月30日间合计减持56.14万股,占公司目前总股本的0.5013%,变动期间该股股价下跌4.78%,截止10月30日收盘报29.7元。股东增减持详情见下表:根据圣诺生物2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100037634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2479771218","title":"开源证券:给予圣诺生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479771218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479771218?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:59","pubTimestamp":1730365175,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对圣诺生物进行研究并发布了研究报告《公司信息更新报告:Q3业绩快速增长,大订单落地助推中长期发展》,本报告对圣诺生物给出买入评级,当前股价为28.91元。截至2024年6月底,公司已拥有19个自主研发的多肽类原料药品种,已取得14个品种多肽原料药生产批件或激活备案。最新盈利预测明细如下:该股最近90天内共有7家机构给出评级,买入评级6家,增持评级1家;过去90天内机构目标均价为32.27。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100032773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","161027"],"gpt_icon":0},{"id":"2479706430","title":"圣诺生物:Q3业绩快速增长 大订单落地助推中长期发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2479706430","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479706430?lang=zh_cn&edition=full","pubTime":"2024-10-31 00:00","pubTimestamp":1730304000,"startTime":"0","endTime":"0","summary":"Q3 业绩快速增长,三大核心子业务整体稳健发展2024Q1-3,公司实现营业收入3.38 亿元,同比增长16.00%;归母净利润5695万元,同比增长63.66%;扣非归母净利润5366 万元,同比增长129.64%。公司三大核心板块稳健发展,多款多肽原料药产品获得海内外备案,3.5 亿元大订单的签订预计将助推原料药业务快速发展。9 月17 日,全资子公司圣诺制药与客户签订金额约3.5 亿元的GLP-1 多肽原料药《产品采购合同》,大订单落地有望助推原料药业务快速成长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410311831319f58f127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410311831319f58f127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2479923490","title":"圣诺生物大幅上涨 获融资净买入818万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479923490","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479923490?lang=zh_cn&edition=full","pubTime":"2024-10-29 09:35","pubTimestamp":1730165710,"startTime":"0","endTime":"0","summary":"资金动向截止发稿,圣诺生物获得主力净流入18万元,其中超大单流入311万元,大单流出293万元。融资融券方面,圣诺生物10月25日获得融资净买入818万元,当日该股融资余额为1.52亿元,当较前一日增加5.70%,实现2连增;该股融券余额为17万元,融券余量为0.53万股,比上日增加32.73%。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029094545ab7d048b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029094545ab7d048b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2479192437","title":"图解圣诺生物三季报:第三季度单季净利润同比增140.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479192437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479192437?lang=zh_cn&edition=full","pubTime":"2024-10-29 01:26","pubTimestamp":1730136383,"startTime":"0","endTime":"0","summary":"证券之星消息,圣诺生物2024年三季报显示,公司主营收入3.38亿元,同比上升16.0%;归母净利润5694.66万元,同比上升63.66%;扣非净利润5365.55万元,同比上升129.64%;其中2024年第三季度,公司单季度主营收入1.39亿元,同比上升18.32%;单季度归母净利润3515.9万元,同比上升140.02%;单季度扣非净利润3453.35万元,同比上升144.8%;负债率39.88%,投资收益62.41万元,财务费用709.41万元,毛利率58.99%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900000822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117"],"gpt_icon":0},{"id":"2478104972","title":"圣诺生物(688117.SH)发布前三季度业绩 净利润5694.66万元 同比增长63.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478104972","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478104972?lang=zh_cn&edition=full","pubTime":"2024-10-28 20:00","pubTimestamp":1730116848,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺生物(688117.SH)披露2024年第三季度报告,该公司前三季度实现营业收入3.38亿元,同比增长16.00%。归属于上市公司股东的净利润5694.66万元,同比增长63.66%。归属于上市公司股东的扣除非经常性损益的净利润5365.55万元,同比增长129.64%。基本每股收益为0.51元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688117"],"gpt_icon":0},{"id":"2478125246","title":"圣诺生物涨5.00% 深圳将支持创新药和创新医疗器械产业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2478125246","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478125246?lang=zh_cn&edition=full","pubTime":"2024-10-28 14:13","pubTimestamp":1730095992,"startTime":"0","endTime":"0","summary":"10月24日,记者从深圳市发展改革委获悉,深圳将发挥科技创新、先进制造、深港合作等优势,支持创新药和创新医疗器械产业健康发展。该委负责制定的《深圳市全链条支持创新药和创新医疗器械发展若干措施》已于10月20日完成社会公众意见征求。此次征求意见的《若干措施》共40条,主要聚焦研发创新、临床试验、注册审批、生产制造、推广应用、金融赋能、数据支撑七大方面,支持创新药和创新医疗器械发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028141339ab7a396e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028141339ab7a396e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159883","688117","159992","BK0239"],"gpt_icon":0},{"id":"2478703611","title":"圣诺生物(688117)10月24日主力资金净卖出923.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478703611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478703611?lang=zh_cn&edition=full","pubTime":"2024-10-25 08:25","pubTimestamp":1729815947,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月24日收盘,圣诺生物报收于28.57元,下跌2.42%,换手率2.14%,成交量2.4万手,成交额6918.49万元。近5日资金流向一览见下表:圣诺生物融资融券信息显示,融资方面,当日融资买入1182.53万元,融资偿还930.6万元,融资净买入251.94万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500008091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2477797023","title":"圣诺生物大跌5.05% 4家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2477797023","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477797023?lang=zh_cn&edition=full","pubTime":"2024-10-21 09:42","pubTimestamp":1729474926,"startTime":"0","endTime":"0","summary":"10月21日,圣诺生物股价大幅下跌,截至09点42分,圣诺生物下跌5.05%,报26.90元/股,成交3479万元,换手率1.12%。此外,数据统计显示,近半年内4家券商给予增持建议,9家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流出598万元,其中超大单流出680万元,大单流入82万元。最新财报显示,今年中报,圣诺生物实现营业收入1.99亿元,同比增长14.44%,净利润为2,178.76万元,同比增长8.14%,基本每股收益为0.19元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021094309ab6b8575&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021094309ab6b8575&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-03","address":"四川省成都市大邑县晋原镇工业大道一段(工业集中发展区内)","stockEarnings":[{"period":"1week","weight":-0.0807},{"period":"1month","weight":-0.0556},{"period":"3month","weight":-0.0111},{"period":"6month","weight":0.1982},{"period":"1year","weight":0.0582},{"period":"ytd","weight":-0.0104}],"companyName":"成都圣诺生物科技股份有限公司","boardCode":"AI0027","perCapita":"22461股","boardName":"医药制造业","registeredCapital":"11241万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 成都圣诺生物科技股份有限公司主营业务是多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。公司主要产品为制剂、原料药、药学研究服务、受托加工服务、定制生产。公司及子公司拥有发明专利32项、实用新型专利30项(其中2项同时取得国际专利)和大量非专利技术,先后获评国家级、省级科研和技术改造项目十余项。","serverTime":1734697859559,"listedPrice":17.9,"stockholders":"5005人(较上一季度减少21.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺生物,688117,圣诺生物股票,圣诺生物股票老虎,圣诺生物股票老虎国际,圣诺生物行情,圣诺生物股票行情,圣诺生物股价,圣诺生物股市,圣诺生物股票价格,圣诺生物股票交易,圣诺生物股票购买,圣诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}